In the wake of the increase in Current Liabilities in the third quarter 2026, Quick Ratio fell to 0.66 below Bionano Genomics Inc average.

Within Laboratory Analytical Instruments industry 12 other companies have achieved higher Quick Ratio than Bionano Genomics Inc in third quarter 2026. While Quick Ratio total ranking in the third quarter 2026 has deteriorated compared to the prior quarter from 1513 to 1940.

Explain Quick Ratio?
How much Cash & cash equivalents BNGO�s has?
What are BNGO�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/BNGO/financial-strength

https://api.csimarket.com/api/v1/companies/BNGO/fundamentals

https://api.csimarket.com/api/v1/companies/BNGO/fundamentals?mode=as_of&as_of=YYYY-MM-DD

Programmatic access for models, analytics, and integration workflows.

Explore the Financial Data API

Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery

Connect Your AI Assistant

How to Connect Your AI Assistant to CSIMarket MCP MCP Server

Access this full dataset via API

Free sample Full docs All endpoints

BNGO Quick Ratio	(Sep 30 2026) Q3	(Jun 30 2026) Q2	(Mar 31 2026) Q1	(Dec 31 2025) Q4	(Sep 30 2025) Q3
Y / Y Current Liabilities Change	-46.44 %	Subscribe	Subscribe	Subscribe	Subscribe
Y / Y Cash & cash equivalent Change	-74.35 %	Subscribe	Subscribe	Subscribe	Subscribe
Quick Ratio MRQ	0.66	Subscribe	Subscribe	Subscribe	Subscribe
BNGO's Total Ranking	# 1940	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Current Liabilities Change	22.59 %	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Cash & cash equivalent Change	-21.61 %	Subscribe	Subscribe	Subscribe	Subscribe

Quick Ratio third quarter 2026 Company Ranking
Within:	No.
Laboratory Analytical Instruments Industry	# 13
Healthcare Sector	# 618
Overall Market	# 1940

Quick Ratio Statistics
High	Average	Low
52.72	5.51	0.06
(Mar 31 2021)		(Dec 31 2017)

Financial Statements
Bionano Genomics Inc 's Current Liabilities	$ 12 Millions	Visit BNGO's Balance sheet
Bionano Genomics Inc 's Cash & cash equivalent	$ 8 Millions	Visit BNGO's Balance sheet
Source of BNGO's Sales		Visit BNGO's Sales by Geography

Cumulative Bionano Genomics Inc 's Quick Ratio

BNGO's Quick Ratio for the trailling 12 Months

BNGO Quick Ratio	(Sep 30 2026) 12 Months	(Jun 30 2026) 12 Months	(Mar 31 2026) 12 Months	(Dec 31 2025) 12 Months	(Sep 30 2025) 12 Months
Y / Y Current Liabilities TTM Growth	-40.03 %	Subscribe	Subscribe	Subscribe	Subscribe
Y / Y Cash & cash equivalent TTM Growth	-19.67 %	Subscribe	Subscribe	Subscribe	Subscribe
Quick Ratio TTM	1.32	Subscribe	Subscribe	Subscribe	Subscribe
Total Ranking TTM	# 4027	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Current Liabilities TTM Growth	-13.82 %	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Cash & cash equivalent TTM Growth	-21.29 %	Subscribe	Subscribe	Subscribe	Subscribe

Quick ratio ranking by company, industry and sector >> Back to BNGO Financial Strength Comparisons >> Go to Compare BNGO Quick Ratio to its Competitors

On the trailing twelve months basis In spite of the year on year decrease in BNGO's Current Liabilities to $12.31 millions, cumulative Quick Ratio to 1.32 below the BNGO average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Laboratory Analytical Instruments industry 21 other companies have achieved higher Quick Ratio than Bionano Genomics Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2026 from 3097 to 4027.

Explain Quick Ratio?
How much Cash & cash equivalents BNGO�s has?
What are BNGO�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Laboratory Analytical Instruments Industry	# 22
Healthcare Sector	# 901
Within the Market	# 4027

trailing twelve months Quick Ratio Statistics
High	Average	Low
19.62	2.85	0.37
(Sep 30 2021)		(Jun 30 2023)

Companies with similar Quick Ratio in the quarter ending Sep 30 2026, within Laboratory Analytical Instruments Industry	Quick Ratio	Sep 30 2026 MRQ Cash & cash equivalent	Sep 30 2026 MRQ Current Liabilities
Quanterix Corporation	1.51	$ 77.359 Millions	$ 51.130 Millions
Nautilus Biotechnology Inc	1.07	$ 10.467 Millions	$ 9.758 Millions
Precipio inc	0.90	$ 3.576 Millions	$ 3.985 Millions
Bio rad Laboratories Inc	0.86	$ 837.100 Millions	$ 969.100 Millions
Bionano Genomics Inc	0.66	$ 8.168 Millions	$ 12.307 Millions
Revvity Inc	0.63	$ 592.799 Millions	$ 936.977 Millions
Avantor Inc	0.34	$ 464.300 Millions	$ 1,369.000 Millions
Waters Corporation	0.27	$ 593.000 Millions	$ 2,180.000 Millions
Harvard Bioscience Inc	0.19	$ 4.856 Millions	$ 26.127 Millions

Date modified: 2026-11-12T05:51:30+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.